Cargando…
Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission
BACKGROUND: In high-transmission areas, developing immunity to symptomatic Plasmodium falciparum infections requires 2–10 years of uninterrupted exposure. Delayed malaria-immunity has been attributed to difficult-to-develop and then short-lived antibody responses. METHODS: In a study area with <0...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2557017/ https://www.ncbi.nlm.nih.gov/pubmed/18782451 http://dx.doi.org/10.1186/1475-2875-7-173 |
_version_ | 1782159621136318464 |
---|---|
author | Torres, Katherine J Clark, Eva H Hernandez, Jean N Soto-Cornejo, Katherine E Gamboa, Dionicia Branch, OraLee H |
author_facet | Torres, Katherine J Clark, Eva H Hernandez, Jean N Soto-Cornejo, Katherine E Gamboa, Dionicia Branch, OraLee H |
author_sort | Torres, Katherine J |
collection | PubMed |
description | BACKGROUND: In high-transmission areas, developing immunity to symptomatic Plasmodium falciparum infections requires 2–10 years of uninterrupted exposure. Delayed malaria-immunity has been attributed to difficult-to-develop and then short-lived antibody responses. METHODS: In a study area with <0.5 P. falciparum infections/person/year, antibody responses to the MSP1-19kD antigen were evaluated and associations with P. falciparum infections in children and adults. In months surrounding and during the malaria seasons of 2003–2004, 1,772 participants received ≥6 active visits in one study-year. Community-wide surveys were conducted at the beginning and end of each malaria season, and weekly active visits were completed for randomly-selected individuals each month. There were 79 P. falciparum infections with serum samples collected during and approximately one month before and after infection. Anti-MSP1-19kD IgG levels were measured by ELISA. RESULTS: The infection prevalence during February-July was similar in children (0.02–0.12 infections/person/month) and adults (0.03–0.14 infections/person/month) and was negligible in the four-month dry season. In children and adults, the seroprevalence was maintained in the beginning (children = 28.9%, adults = 61.8%) versus ending malaria-season community survey (children = 26.7%, adults = 64.6%). Despite the four-month non-transmission season, the IgG levels in Plasmodium-negative adults were similar to P. falciparum-positive adults. Although children frequently responded upon infection, the transition from a negative/low level before infection to a high level during/after infection was slower in children. Adults and children IgG-positive before infection had reduced symptoms and parasite density. CONCLUSION: Individuals in low transmission areas can rapidly develop and maintain αMSP1-19kD IgG responses for >4 months, unlike responses reported in high transmission study areas. A greater immune capacity might contribute to the frequent asymptomatic P. falciparum infections in this Peruvian population. |
format | Text |
id | pubmed-2557017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25570172008-10-02 Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission Torres, Katherine J Clark, Eva H Hernandez, Jean N Soto-Cornejo, Katherine E Gamboa, Dionicia Branch, OraLee H Malar J Research BACKGROUND: In high-transmission areas, developing immunity to symptomatic Plasmodium falciparum infections requires 2–10 years of uninterrupted exposure. Delayed malaria-immunity has been attributed to difficult-to-develop and then short-lived antibody responses. METHODS: In a study area with <0.5 P. falciparum infections/person/year, antibody responses to the MSP1-19kD antigen were evaluated and associations with P. falciparum infections in children and adults. In months surrounding and during the malaria seasons of 2003–2004, 1,772 participants received ≥6 active visits in one study-year. Community-wide surveys were conducted at the beginning and end of each malaria season, and weekly active visits were completed for randomly-selected individuals each month. There were 79 P. falciparum infections with serum samples collected during and approximately one month before and after infection. Anti-MSP1-19kD IgG levels were measured by ELISA. RESULTS: The infection prevalence during February-July was similar in children (0.02–0.12 infections/person/month) and adults (0.03–0.14 infections/person/month) and was negligible in the four-month dry season. In children and adults, the seroprevalence was maintained in the beginning (children = 28.9%, adults = 61.8%) versus ending malaria-season community survey (children = 26.7%, adults = 64.6%). Despite the four-month non-transmission season, the IgG levels in Plasmodium-negative adults were similar to P. falciparum-positive adults. Although children frequently responded upon infection, the transition from a negative/low level before infection to a high level during/after infection was slower in children. Adults and children IgG-positive before infection had reduced symptoms and parasite density. CONCLUSION: Individuals in low transmission areas can rapidly develop and maintain αMSP1-19kD IgG responses for >4 months, unlike responses reported in high transmission study areas. A greater immune capacity might contribute to the frequent asymptomatic P. falciparum infections in this Peruvian population. BioMed Central 2008-09-09 /pmc/articles/PMC2557017/ /pubmed/18782451 http://dx.doi.org/10.1186/1475-2875-7-173 Text en Copyright © 2008 Torres et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Torres, Katherine J Clark, Eva H Hernandez, Jean N Soto-Cornejo, Katherine E Gamboa, Dionicia Branch, OraLee H Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission |
title | Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission |
title_full | Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission |
title_fullStr | Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission |
title_full_unstemmed | Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission |
title_short | Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission |
title_sort | antibody response dynamics to the plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 c-terminal 19kd (msp1-19kd), in peruvians exposed to hypoendemic malaria transmission |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2557017/ https://www.ncbi.nlm.nih.gov/pubmed/18782451 http://dx.doi.org/10.1186/1475-2875-7-173 |
work_keys_str_mv | AT torreskatherinej antibodyresponsedynamicstotheplasmodiumfalciparumconservedvaccinecandidateantigenmerozoitesurfaceprotein1cterminal19kdmsp119kdinperuviansexposedtohypoendemicmalariatransmission AT clarkevah antibodyresponsedynamicstotheplasmodiumfalciparumconservedvaccinecandidateantigenmerozoitesurfaceprotein1cterminal19kdmsp119kdinperuviansexposedtohypoendemicmalariatransmission AT hernandezjeann antibodyresponsedynamicstotheplasmodiumfalciparumconservedvaccinecandidateantigenmerozoitesurfaceprotein1cterminal19kdmsp119kdinperuviansexposedtohypoendemicmalariatransmission AT sotocornejokatherinee antibodyresponsedynamicstotheplasmodiumfalciparumconservedvaccinecandidateantigenmerozoitesurfaceprotein1cterminal19kdmsp119kdinperuviansexposedtohypoendemicmalariatransmission AT gamboadionicia antibodyresponsedynamicstotheplasmodiumfalciparumconservedvaccinecandidateantigenmerozoitesurfaceprotein1cterminal19kdmsp119kdinperuviansexposedtohypoendemicmalariatransmission AT branchoraleeh antibodyresponsedynamicstotheplasmodiumfalciparumconservedvaccinecandidateantigenmerozoitesurfaceprotein1cterminal19kdmsp119kdinperuviansexposedtohypoendemicmalariatransmission |